2024 ASCO Annual Meeting
2024 ASCO Annual Meeting
Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 1 – 3:00 PM CDT
location_onHall D1
2024 ASCO Annual Meeting
Rapid Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 3 – 8:00 AM CDT
location_onS406
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.
8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
- Forums
- ASX - By Stock
- SPL
- ASCO Presentations 2024
ASCO Presentations 2024
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.44M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 10.5¢ | $132.0K | 1.162M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 535926 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 535926 | 0.115 |
5 | 840444 | 0.110 |
10 | 464030 | 0.105 |
10 | 301472 | 0.100 |
1 | 10305 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 100000 | 1 |
0.130 | 263052 | 6 |
0.135 | 53056 | 4 |
0.140 | 98397 | 7 |
0.145 | 200605 | 6 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
12.0¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
11.0¢ | 12.5¢ | 10.5¢ | 991112 | ||
Last updated 15.53pm 03/05/2024 ? |
Featured News
SPL (ASX) Chart |